Hsu, Wei-FanWei-FanHsuLai, Hsueh-ChouHsueh-ChouLaiSu, Wen-PangWen-PangSuLin, Chia-HsinChia-HsinLinChuang, Po-HengPo-HengChuangChen, Sheng-HungSheng-HungChenChen, Hung-YaoHung-YaoChenWang, Hung-WeiHung-WeiWangGUAN-TARN HUANGPeng, Cheng-YuanCheng-YuanPeng2024-03-262024-03-262019-04-271471-230Xhttps://www.scopus.com/record/display.uri?eid=2-s2.0-85064979554&doi=10.1186%2fs12876-019-0973-5&origin=inward&txGid=3fa5070fb687a3976ef90b3642ba7d53https://scholars.lib.ntu.edu.tw/handle/123456789/641386Studies on temporal changes in noninvasive fibrosis indices and liver stiffness measurement (LSM) in patients with chronic hepatitis C (CHC) treated with direct-acting antiviral agents (DAAs) are limited.enAspartate aminotransferase/platelet ratio index (APRI); Chronic hepatitis C; Direct-acting antiviral agents; FIB-4; Liver stiffness measurement; Noninvasive fibrosis index; Platelet[SDGs]SDG3Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agentsjournal article10.1186/s12876-019-0973-5310291012-s2.0-85064979554https://api.elsevier.com/content/abstract/scopus_id/85064979554